Corebridge Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,128	Closed	-$575K	–	125
2025 Q1	$575K	Sell	2,128 -81	-4%	-$21.9K	﹤0.01%	1510
2024 Q4	$520K	Sell	2,209 -50	-2%	-$11.8K	﹤0.01%	1666
2024 Q3	$621K	Sell	2,259 -81	-3%	-$22.3K	﹤0.01%	1618
2024 Q2	$569K	Buy	+2,340	New	+$569K	﹤0.01%	1623